Over-The-Counter Tests Market Size is anticipated to expand at a stable pace from 2022 to 2028, pushed by the rising reliance on these home-based solutions amidst the coronavirus pandemic. Growing percentage of geriatric population, increased disposable incomes, and higher affordability of these tests are some of the major drivers pushing the growth of this market. As patients aged 65 years and above are at a higher risk of infection, taking over-the-counter tests can be an effective way of protecting them from the virus.
The over-the-counter pregnancy tests industry share is expected to expand steadily between 2022 and 2028. The rising preference for non-invasive testing will ensure that the over-the-counter urine pregnancy tests market will advance further. Several women are likely to opt for saliva-based solutions, which are deemed more dignified as the dependence on urine or blood samples is eliminated.
The launch of innovative testing solutions is ensuring that the over-the-counter tests market participants stay ahead of their game. In November 2021, SaliStick, announced that has successfully completed clinical trials for the world’s first saliva-based rapid pregnancy test kit. The product, developed by Jerusalem-based diagnostics products provider, Salignostics, can detect β-hCG as early as the next day after a missed period.
The online pharmacies segment might generate a continual inflow of revenue through 2028. Since the outbreak of the pandemic, the number of online customers has been growing across these platforms. As more people are inclined toward the use of smartphones and other mobile devices for ordering medicines and other pharma products, offline medical stores are migrating to digital platforms.
The growing concerns over drug safety are fueling the over-the-counter tests market share from the online pharmacy segment. E-pharma adoption reduces the long waiting times, at the same time providing higher discounts and countering medicine unavailability. As per the National Investment Promotion & Facilitation Agency of India, there has been a significant rise in investor interest across the e-pharmacy industry in India, which has attracted over $700 million during 2020.
North America over-the-counter tests market share is poised to rise during the forecast timeline, supported by the favorable government policies and funding activities. In December 2021, U.S. President Joe Biden announced his plan to make at-home COVID-19 tests extensively available to the regional population. These kits will be made available free of charge in anticipation of the omicron variant surge. Alaskan citizens can also pick up free COVID testing kits from their nearest community hospitals & health centers.
The growing footprint of newer strains of diseases including dengue and malaria across the region are influencing Latin America over-the-counter tests market outlook. With a significant rise in the number of various disorders and diseases, the dependence on these testing strips has grown considerably across small clinics since the last couple of years. In December 2020, the government of New Mexico announced the launch of free self-administered COVID-19 saliva tests. It signed a contract with Vault Medical Services, who will provide the kit and test results within 48 hours. Nearly 9,300 New Mexicans availed of these kits, boosting the regional growth.
The COVID-19 pandemic had a positive effect of the global industry value. Since 2020, the rapidly spreading COVID-19 infection has been encouraging individuals to opt for at-home solutions to prevent the risk of contagion. Healthcare agencies and practitioners are encouraging the use of these tests with a view to minimize the number of patient visits. Numerous global entities are working toward making testing and diagnostic tools more accessible and affordable.
For instance, the FDA recommends the use of home-use blood glucose meters and test strips amongst hospitalized diabetes patients and those residing in nursing homes and assisted living facilities to protect healthcare providers and patients from exposure to infection.
Market, by product
Market, by End-use
The above information is provided for the following regions and countries: